Diabetes Therapy
Palmitate-derivatized GLP-1 analogues exhibit antihyperglycemic action
Published in Obesity and Diabetes Week, May 17th, 2004
"The hormone glucagon-like peptide-1(736)amide (GLP-1) is released in response to ingested nutrients and acts to promote glucose-dependent insulin secretion ensuring efficient postprandial glucose homeostasis. Unfortunately, the beneficial actions of GLP-1 which give this hormone many of the desirable properties of an antidiabetic drug are short lived due to degradation by dipeptidylpeptidase IV (DPP IV) and rapid clearance by renal filtration," scientists in Ireland report.
"In this study we have attempted to extend GLP-1 action through the attachment of palmitoyl moieties...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Obesity and Diabetes Week
More Articles from Obesity and Diabetes Week
- Diabetes
Preliminary optimal indication for nateglinide released - Diabetes Pathogenesis
PPAR-alpha deficiency does not alter insulin sensitivity in mice - Diet and Nutrition
Glucose and insulin preprandial profiles differentiate meals and snacks - Obesity and Diabetes
Protein restriction affects fetal and adult rat pancreas differently - Obesity and Diabetes
Retinoids offer novel strategies for obesity and diabetes treatment - Anxiety Disorder
Case of anxiety disorder related to diabetes reported - More from this issue of Obesity and Diabetes Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
